RNAC

Cartesian Therapeutics, Inc.

RNAC · CIK 1453687 · Annual (10-K) · Last 7 years

Financial Trends

Revenue$39M
20162024
Net Income−$77M
20162024
Operating CF−$24M
20162024
Free Cash Flow−$33M
20162024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2016↕
Revenue$0.0B$0.0B$0.1B$0.1B$0.0B$0.0B$0.0B
Cost of Revenue———————
Gross Profit———————
R&D Expense$0.0B$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B
SG&A Expense———————
Operating Income$-0.0B$-0.1B$0.0B$-0.0B$-0.1B$-0.1B$-0.0B
Net Income$-0.1B$-0.2B$0.0B$-0.0B$-0.1B$-0.0B$-0.0B
EPS (Basic)$-4.48$-1.66$0.24$-0.22———
EPS (Diluted)$-4.49$-1.66$0.10$-0.22———

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2016↕
Total Assets$0.4B$0.3B$0.2B$0.2B$0.2B$0.1B$0.1B
Current Assets$0.2B$0.1B$0.1B$0.1B$0.2B$0.1B$0.1B
Cash & Equivalents$0.2B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Total Liabilities$0.4B$0.4B$0.1B$0.1B$0.2B$0.1B$0.0B
Current Liabilities$0.0B$0.1B$0.0B$0.1B$0.1B$0.0B$0.0B
Stockholders' Equity$-0.0B$-0.4B$0.1B$0.0B$-0.0B$0.0B$0.1B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2016↕
Operating Cash Flow$-0.0B$-0.1B$-0.0B$-0.1B$0.0B$-0.1B—
Investing Cash Flow$-0.0B$0.0B$-0.0B$-0.0B$-0.0B$0.0B—
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.2B$-0.0B$0.0B$0.1B$0.0B$0.1B—
← Companies